Clinical Trials Logo

Clinical Trial Summary

To study the effect of coenzyme Q10 on semen parameters in men with idiopathic infertility


Clinical Trial Description

Decreased serum CoQ10 concentrations as well as a decrease in the CoQ10H2 to-ubiquinone ratio have been demonstrated in diseases associated with OS. A strong correlation among sperm count, motility and ubiquinol-10 levels in seminal fluid has also been reported.

The aim of the present study is to investigate whether the effects of the exogenous administration of ubiquinol in the improvement of semen parameters in Pakistani men population.

Patients who full filled the inclusion criteria and gave informed written consent will be included in the trial. Patient will start to take medication and will take it for 26 weeks.

All men undergo a thorough physical examination, a detail history, serum biochemical and hematological laboratory tests and measurement of serum sex and thyroid hormone levels. A questionnaire will be used to collect information on demographic characteristics. Two semen samples 1 and 2 month apart will be obtained after 3 to 5 days of sexual abstinence and process within 1 hour of ejaculation. The mean of the two will be used for statistical analysis. Semen analyses will be performed using WHO recommended methods.

3 ml of blood will be withdrawn from the patient for the serum hormones analysis and total amount of semen will required for analysis of semen parameters.

Sponsor will bear the test cost of patient during the study treatment period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03104998
Study type Interventional
Source PharmEvo Pvt Ltd
Contact
Status Withdrawn
Phase Phase 4
Start date August 1, 2017
Completion date May 30, 2018

See also
  Status Clinical Trial Phase
Completed NCT00805662 - Nasal Oxcytocin During IUI N/A
Not yet recruiting NCT05156684 - Effect of Pentoxifylline and Zinc Co-administration in Patients With Oligoasthenoteratozoospermia N/A